
How to Plan Your ESMO Asia 2026 Schedule Without Missing Key Sessions
ESMO Asia 2026 brings three days of important oncology research, clinical insights and expert discussions to Singapore. But with multiple sessions, posters and KOL meetings happening across the congress, planning your schedule carefully is essential if you don't want to miss the data that matters.
ESMO Asia 2026 runs from 4 to 6 December 2026 at the Suntec Singapore Convention & Exhibition Centre. For Medical Affairs and oncology marketing teams, a clear ESMO Asia 2026 schedule is only half the job. The other half is what happens to that data once the congress ends.
New oncology data creates a short window. Field teams want updated decks, HCPs want clear summaries, and every asset still needs medical, legal and regulatory (MLR) review before it goes out.
This guide covers how to plan your sessions, capture the right data in Singapore, and turn it into finished, MLR-ready content while it still matters.
How to plan your ESMO Asia 2026 schedule, step by step
1. Start with the official ESMO Asia 2026 program
The congress program is published on the ESMO website ahead of the meeting. Flag every session in your therapy areas, plus competitor data and trials your brand is following. Check it again in the week before you travel, as sessions are added and moved.
2. Rank sessions by what your team needs
Rank sessions in three tiers, based on the content you'll need to create afterward:
- Must attend: late-breaking abstracts and proffered papers in your therapy area, and any data on your own or competing molecules.
- Want to attend: adjacent tumor types, new mechanisms of action and trial designs your field teams will be asked about.
- If there's time: industry symposia, educational sessions and networking events.
3. Divide and cover as a team
Two key sessions often run at the same time. If several colleagues are attending, assign each person sessions in advance so nothing is covered twice and nothing is missed. Agree on one shared place for everyone's notes.
4. Block time for posters
Posters often carry the detailed data that ends up in field materials. Put poster time in your schedule as a fixed block, and list the poster numbers you need so you can go straight to them.
5. Leave buffers between halls
Suntec is a large venue. Leave 10 to 15 minutes between sessions in different halls, and use the gaps to note what each session means for your content plan.
6. Plan KOL meetings around sessions
Book meetings with key opinion leaders and partners during breaks, not on top of sessions you need to cover. Their reaction to new data is useful input for the content you'll build later.
During ESMO Asia: capture data you can build content from
What you capture in Singapore becomes the raw material for your post-congress content. If it isn't sourced, it can't go through MLR review.
- Track the source of every data point. Note the abstract number, session and presenter next to each finding. A claim without a source has to be checked again later.
- Collect the published version. Abstracts and publications are what your content will cite, so download them as they become available.
- Write down field questions. Note what HCPs and KOLs ask about the data. Those questions tell you which content to build first.
- Respect congress rules. Follow the congress's policy on photographing and sharing presentations, and respect embargoes.
After the congress: turn ESMO Asia data into MLR-ready content
The usual route from congress data to field-ready content is slow. A brief goes to an agency, drafts go back and forth, and every claim is checked against its source before MLR review can start.
Bionidi shortens that route. It's a scientific content platform for Medical Affairs and marketing teams that turns approved publications and brand materials into finished content:
- Slide decks, including oncology MOA and KOL decks.
- Medical explainer videos and infographics.
- E-detailers and e-learning modules for field medical education.
Every claim is linked to its source with a page and section reference, and an MLR evidence report is created as the content is built. You review and approve the content plan before anything is generated, and your brand colours, fonts and voice are applied throughout.
Bionidi doesn't replace MLR review. It gives your reviewers sourced, traceable content to approve, so new ESMO Asia 2026 data can reach your field teams sooner.
Are you headed to ESMO Asia Singapore?
So are we. The Bionidi team will be at ESMO Asia 2026, and we'd love to meet you.
Whether you're part of a Medical Affairs team, scientific communications team or oncology marketing team, let's talk about how you turn congress insights into effective medical content.
Meet us in Singapore or contact us at [email protected].
Book a demo to see how your ESMO Asia data can become finished content.